Neuron
Volume 46, Issue 1, 7 April 2005, Pages 65-74
Journal home page for Neuron

Article
Corelease of Dopamine and Serotonin from Striatal Dopamine Terminals

https://doi.org/10.1016/j.neuron.2005.02.010Get rights and content
Under an Elsevier user license
open archive

Summary

The striatum receives rich dopaminergic and more moderate serotonergic innervation. After vesicular release, dopamine and serotonin (5-hydroxytryptamine, 5-HT) signaling is controlled by transporter-mediated reuptake. Dopamine is taken up by dopamine transporters (DATs), which are expressed at the highest density in the striatum. Although DATs also display a low affinity for 5-HT, that neurotransmitter is normally efficiently taken up by the 5-HT transporters. We found that when extracellular 5-HT is elevated by exogenous application or by using antidepressants (e.g., fluoxetine) to inhibit the 5-HT transporters, the extremely dense striatal DATs uptake 5-HT into dopamine terminals. Immunohistochemical results and measurements using fast cyclic voltammetry showed that elevated 5-HT is taken up by DATs into striatal dopamine terminals that subsequently release 5-HT and dopamine together. These results suggest that antidepressants that block serotonin transporters or other factors that elevate extracellular 5-HT alter the temporal and spatial relationship between dopamine and 5-HT signaling in the striatum.

Cited by (0)

3

Present address: Department of Pharmacology, University of Tennessee, Memphis, Tennessee 38163.